Trial Profile
Phase I trial of NTC-801 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 14 Dec 2015
Price :
$35
*
At a glance
- Drugs NTC 801 (Primary)
- Indications Atrial fibrillation; Atrial flutter
- Focus Adverse reactions
- 14 Dec 2015 New trial record